Characterization of swine isolates of clostridium difficile in Spain: A potential source of epidemic multidrug resistant strains?

Anaerobe

Volumn 22, Issue , 2013, Pages 45-49

  Peláez, Teresa ^a,b   Alcalá, Luis ^a   Blanco, José L ^b   Álvarez Pérez, Sergio ^a   Marín, Mercedes ^a,b   Martín López, Adoración ^a   Catalán, Pilar ^a   Reigadas, Elena ^a   García, Marta E ^b   Bouza, Emilio ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Clostridium difficile; Multidrug resistance; Ribotypes; Swine; Toxins

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; DAPTOMYCIN; ERTAPENEM; ERYTHROMYCIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CYTOTOXICITY; GEOGRAPHIC ORIGIN; IMMUNOASSAY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RIBOTYPING; SPAIN; SWINE; TOXIN SYNTHESIS;

CLOSTRIDIUM DIFFICILE; MULTIDRUG RESISTANCE; RIBOTYPES; SWINE; TOXINS;

ANIMALS; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DISEASE RESERVOIRS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; PREVALENCE; RIBOTYPING; SPAIN; SWINE;

ANIMALIA; CLOSTRIDIUM DIFFICILE; SUIDAE;

EID: 84880717358     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.05.009     Document Type: Article

References (53)

1. Hensgens M.P., Keessen E.C., Squire M.M., Riley T.V., Koene M.G., de Boer E., et al. Clostridium difficile infection in the community: a zoonotic disease?. Clin Microbiol Infect 2012, 18:635-645. on behalf of European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD).
2. Keessen E.C., Gaastra W., Lipman L.J. Clostridium difficile infection in human and animals, differences and similarities. Vet Microbiol 2011, 153:205-217.
3. Bartlett J.G., Gerding D.N. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008, 46:S12-S18.
4. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
5. Carroll K.C., Bartlett J.G. Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu Rev Microbiol 2011, 65:501-521.
6. Denève C., Janoir C., Poilane I., Fantinato C., Collignon A. New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents 2009, 33:S24-S28.
7. Kelly C.P., LaMont J.T. Clostridium difficile- more difficult than ever. NEngl J Med 2008, 359:1932-1940.
8. Khanna S., Pardi D.S., Aronson S.L., Kammer P.P., Orenstein R., St Sauver J.L., et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012, 107:89-95.
9. Kuijper E.J., Coignard B., Tüll P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006, 12:2-18. ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and control.
10. Costa M.C., Reid-Smith R., Gow S., Hannon S.J., Booker C., Rousseau J., et al. Prevalence and molecular characterization of Clostridium difficile isolated from feedlot beef cattle upon arrival and mid-feeding period. BMC Vet Res 2012, 8:38.
11. Debast S.B., van Leengoed L.A., Goorhuis A., Harmanus C., Kuijper E.J., Bergwerff A.A. Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol 2009, 11:505-511.
12. Hopman N.E., Keessen E.C., Harmanus C., Sanders I.M., van Leengoed L.A., Kuijper E.J., et al. Acquisition of Clostridium difficile by piglets. Vet Microbiol 2011, 149:186-192.
13. Keel K., Brazier J.S., Post K.W., Weese S., Songer J.G. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves and other species. JClin Microbiol 2007, 45:1963-1964.
14. Keessen E.C., van den Berkt A.J., Haasjes N.H., Hermanus C., Kuijper E.J., Lipman L.J. The relation between farm specific factors and prevalence of Clostridium difficile in slaughter pigs. Vet Microbiol 2011, 154:130-134.
15. Koene M.G., Mevius D., Wagenaar J.A., Harmanus C., Hensgens M.P., Meetsma A.M., et al. Clostridium difficile in Dutch animals: their presence, characteristics and similarities with human isolates. Clin Microbiol Infect 2012, 18:778-784.
16. Rodriguez-Palacios A., Pickworth C., Loerch S., LeJeune J.T. Transient fecal shedding and limited animal-to-animal transmission of Clostridium difficile by naturally infected finishing feedlot cattle. Appl Environ Microbiol 2011, 77:3391-3397.
17. Weese J.S., Wakeford T., Reid-Smith R., Rousseau J., Friendship R. Longitudinal investigation of Clostridium difficile shedding in piglets. Anaerobe 2010, 16:501-504.
18. Curry S.R., Marsh J.W., Schlackman J.L., Harrison L.H. Clostridium difficile prevalence in uncooked ground meat products from Pittsburgh, PA. Appl Environ Microbiol 2012, 78:4183-4186.
19. Songer J.G., Trinh H.T., Killgore G.E., Thompson A.D., McDonald L.C., Limbago B.M. Clostridium difficile in retail meat products, USA. Emerg Infect Dis 2007, 15(2009):819-821.
20. Weese J.S., Avery B.P., Rousseau J., Reid-Smith R.J. Detection and enumeration of Clostridium difficile spores in retail beef and pork. Appl Environ Microbiol 2009, 75:5009-5011.
21. Weese J.S., Reid-Smith R.J., Avery B.P., Rousseau J. Detection and characterization of Clostridium difficile in retail chicken. Lett Appl Microbiol 2010, 50:362-365.
22. Dubberke E.R., Haslam D.B., Lanzas C., Bobo L.D., Burnham C.A., Gröhn Y.T., et al. The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge. Zoonoses Public Health 2011, 58:4-20.
23. Norman K.N., Scott H.M., Harvey R.B., Norby B., Hume M.E., Andrews K. Prevalence and genotypic characteristics of Clostridium difficile in a closed and integrated human and swine population. Appl Environ Microbiol 2011, 77:5755-5760.
24. Álvarez-Pérez S., Blanco J.L., Bouza E., Alba P., Gibert X., Maldonado J., et al. Prevalence of Clostridium difficile in diarrhoeic and non-diarrhoeic piglets. Vet Microbiol 2009, 137:302-305.
25. Alcalá L., Martín A., Marín M., Sánchez-Somolinos M., Catalán P., Peláez T., et al. The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem?. Clin Microbiol Infect 2012, 18:E204-E213. on behalf of the Spanish Clostridium difficile Study Group.
26. Stubbs S., Rupnik M., Gibert M., Brazier J., Duerden B., Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 2000, 186:307-312.
27. Stubbs S.L., Brazier J.S., O'Neill G.L., Duerden B.I. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. JClin Microbiol 1999, 37:461-463.
28. Clinical and Laboratory Standards Institute (CLSI) Methods for antimicrobial susceptibility testing of anaerobic bacteria 2007, Approved standard M11-A7, CLSI, Wayne, PA. 7th ed.
29. Peláez T., Cercenado E., Alcalá L., Marín M., Martín-López A., Martínez-Alarcón J., et al. Metronidazole resistance in Clostridium difficile is heterogeneous. JClin Microbiol 2008, 46:3028-3032.
30. European Committee for Antimicrobial Susceptibility Testing (EUCAST). EUCAST clinical breakpoint Tablev. 2.0. p. 62. Available at: [accessed 09.02.13]. http://www.eucast.org/clinical_breakpoints/.
31. Goldstein E.J.C., Citron D.M., Merriam C.V., Warren Y.A., Tyrrell K.L., Fernandez H.T. Comparative invitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents. Antimicrob Agents Chemother 2006, 50:3507-3513.
32. Huang H., Wu S., Wang M., Zhang Y., Fang H., Palmgren A.-C., et al. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. Int J Antimicrob Agents 2009, 33:339-342.
33. Norman K.N., Harvey R.B., Scott H.M., Hume M.E., Andrews K., Brawley A.D. Varied prevalence of Clostridium difficile in an integrated swine operation. Anaerobe 2009, 15:256-260.
34. Peláez T., Alcalá L., Alonso R., Rodríguez-Créixems M., García-Lechuz J.M., Bouza E. Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother 2002, 46:1647-1650.
35. Schwarz S., Silley P., Simjee S., Woodford N., van Duijkeren E., Johnson A.P., et al. Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals. JAntimicrob Chemother 2010, 65:601-604.
36. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing; Vienna, Austria. Available at: [accessed 09.02.13]. http://www.R-project.org.
37. Arroyo L.G., Kruth S.A., Willey B.M., Staempfli H.R., Low D.E., Weese J.S. PCR ribotyping of Clostridium difficile isolates originating from human and animal sources. JMed Microbiol 2005, 54:163-166.
38. Bakri M.M., Sutherland A.D., Brown D.J., Vesely P., Crossan C., Scobie L. Assessment of the potential risk of infection associated with Clostridium difficile from porcine xenografts. Xenotransplantation 2009, 16:472-476.
39. Janezic S., Ocepek M., Zidaric V., Rupnik M. Clostridium difficile genotypes other than ribotype 078 that are prevalent among human, animal and environmental isolates. BMC Microbiol 2012, 12:48.
40. Rodriguez-Palacios A., Stämpfli H.R., Duffield T., Peregrine A.S., Trotz-Williams L.A., Arroyo L.G., et al. Clostridium difficile PCR ribotypes in calves, Canada. Emerg Infect Dis 2006, 12:1730-1736.
41. Martin H., Willey B., Low D.E., Staempfli H.R., McGeer A., Boerlin P., et al. Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006. JClin Microbiol 2008, 46:2999-3004.
42. Bauer M.P., Notermans D.W.E., van Benthem B.H.B., Brazier J.S., Wilcox M.H., Rupnik M., et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377:63-73. on behalf of the ECDIS Study Group.
43. Taori S.K., Hall V., Poxton I.R. Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004. JMed Microbiol 2010, 59:338-344.
44. Karlowsky J.A., Zhanel G.G., Hammond G.W., Rubinstein E., Wylie J., Du T., et al. Multidrug-resistant North American pulsotype 2 Clostridium difficile was the predominant toxigenic hospital-acquired strain in the province of Manitoba, Canada, in 2006-2007. JMed Microbiol 2012, 61:693-700.
45. Wüst J., Sullivan N.M., Hardegger U., Wilkins T.D. Investigation of an outbreak of antibiotic-associated colitis by various typing methods. JClin Microbiol 1982, 16:1096-1101.
46. Thakur S., Putnam M., Fry P.R., Abley M., Gebreyes W.A. Prevalence of antimicrobial resistance and association with toxin genes in Clostridium difficile in commercial swine. Am J Vet Res 2010, 71:1189-1194.
47. Huang H., Fang H., Weintraub A., Nord C.E. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect 2009, 15:1170-1173.
48. Baines S.D., O'Connor R., Freeman J., Fawley W.N., Harmanus C., Mastrantonio P., et al. Emergence of reduced susceptibility to metronidazole in Clostridium difficile. JAntimicrob Chemother 2008, 62:1046-1052.
49. Barbut F., Decré D., Burghoffer B., Lesage D., Delisle F., Lalande V., et al. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother 1999, 43:2607-2611.
50. Huang H., Weintraub A., Fang H., Wu S., Zhang Y., Nord C.E. Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains. Anaerobe 2010, 16:633-635.
51. Sánchez-Somolinos M., Alcalá L., Peláez T., Marín M., Martín A., Catalán P., et al. High levels of resistance to fluoroquinolones among Clostridium difficile isolates in a Spanish hospital. Clin Infect Dis 2008, 47:818-822.
52. Wong S.S., Woo P.C., Luk W.K., Yuen K.Y. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest. Diagn Microbiol Infect Dis 1999, 34:1-6.
53. Jang S.S., Hansen L.M., Breher J.E., Riley D.A., Magdesian K.G., Madigan J.E., et al. Antimicrobial susceptibilities of equine isolates of Clostridium difficile and molecular characterization of metronidazole-resistant strains. Clin Infect Dis 1997, 25:S266-S267.